When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APVO - Aptevo Therapeutics begins phase 1 trial of APVO210; shares up 11% premarket
Aptevo Therapeutics Inc.
Aptevo Therapeutics (NASDAQ:APVO) has commenced dosing in a Phase 1 clinical trial of APVO210, a novel bispecific antibody candidate built on ADAPTIR therapeutic protein platform developed to treat autoimmune and inflammatory diseases.
More news on: Aptevo Therapeutics Inc., Healthcare stocks news, Stocks on the move,